Cees Wortel

Private Equity Investor bei

Vesalius Biocapital Partners SARL

Health Technology

Consumer Services

Finance

Profil

Cees Wortel currently works at Vesalius Biocapital Partners SARL, as Venture Partner from 2016.
Dr. Wortel also formerly worked at Galapagos NV, as Chief Medical Officer.
Dr. Wortel received his doctorate degree in 1993 from the University of Amsterdam.

Aktive Positionen von Cees Wortel

Unternehmen	Position	Beginn
Vesalius Biocapital Partners SARL Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors.	Private Equity Investor	01.01.2016

Alle aktiven Positionen von Cees Wortel

Ehemalige bekannte Positionen von Cees Wortel

Unternehmen	Position	Ende
LAKEFRONT BIOTHERAPEUTICS NV	Technik-/Wissenschafts-/F&E-Leiter	-

Sehen Sie sich die Erfahrung von Cees Wortel im Detail an

Ausbildung von Cees Wortel

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Cees Wortel im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	3
Galapagos NV Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology	Health Technology
University of Amsterdam University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vesalius Biocapital Partners SARL Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners invests in companies located in Europe. The firm targets companies operating in the fields of life science, therapeutics, medical devices and diagnostics sectors. It provides financing for seed, early and later stage capital requirements with an investment size of up to USD 10 million. It acts as a lead & co-investor and acquires majority interest and also takes a seat on the board of directors.	Finance